Ignite Creation Date:
2025-12-24 @ 1:03 PM
Ignite Modification Date:
2025-12-30 @ 1:48 AM
Study NCT ID:
NCT04338061
Status:
TERMINATED
Last Update Posted:
2025-03-21
First Post:
2020-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MS200527_0082
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |